Key Information

Market : EURONEXT Paris (Compartment B)
Trading: Continuous
ISIN code: FR0000054694
TICKER: NRX
REUTERS: NATU.PA
BLOOMBERG: NRX:FP
DR Symbol: NTUXY
Sector: Food Industry
Indices : CACT, CAC® PME, CAC Mid & Small, CAC Small, Gaïa Index
Eligible for the “long-only” Deferred Settlement Service (SRD), and French equity plans (PEA and PEA-PME)
ADR (American Depositary receipt) program with BNY Mellon

Number of shares as at 31 October 2017: 9 276 609
Number of voting rights as at 31 October 2017: 12 423 564 (gross)
and 12 420 998 (exercisable)

 

Share price details

Trading of 01/23/2018 at 04h07

Last price Variation Opening High Low Volume
92.10€ 0.44% 91.50€ 92.30€ 91.40€ 2 408

Since the beginning of the year

High (closing price) Low (closing price) Change since 01/01/2018
94.70€ 86.80€ 4.66%

Intraday

Shareholding

 

31 December 2017

 
 
  Number of shares % of capital % of voting rights (gross)
Treasury Shares - NATUREX S.A (1) 4 899 0.05% 0.04%
SGD (2) 2 306 839 24.16% 26.51%
FINASUCRE 156 825 1.64% 1.57%
Olivier LIPPENS 1 0.00% 0.00%
Paul LIPPENS 1 0.00% 0.00%
Total action in concert SGD/FINASUCRE/LIPPENS (3) 2 463 666 25.80% 28.08%
CARAVELLE 1 400 026 14.66% 22.06%
Hélène MARTEL-MASSIGNAC 117 0.00% 0.00%
Total action in concert CARAVELLE/MARTEL-MASSIGNAC (4) 1 400 143 14.66% 22.06%
Olivier RIGAUD 3 000 0.03% 0.03%
Anne ABRIAT 3 0.00% 0.00%
Miriam MAES 1 0.00% 0.00%
Total other directors NATUREX 3 004 0.03% 0.03%
 ALLIANZ  521 783  5.5%  4.1%
 Bpi Participations  579 651  6.1%  7.7%
 TIKEHAU  314 915  3.3%  4.2%
 Total other identified shareholders  1 416 349  14.83%  16.08%
Public 4 260 680 44.62% 33.72%
TOTAL 9 548 741 100.00% 100.00%
  Treasury shares NATUREX S.A (1)
Number of shares 4 899
% of capital 0.05%
% of voting rights (gross) 0.04%
  SGD (2)
Number of shares 2 306 839
% of capital 24.16%
% of voting rights 26.51%
  FINASUCRE
Number of shares 156 825
% of capital 1.64%
% of voting rights 1.57%
  Olivier LIPPENS
Number of shares 1
% of capital 0.00%
% of voting rights 0.00%
  Paul LIPPENS
Number of shares 1
% of capital 0.00%
% of voting rights 0.00%
   Total action in concert SGD/FINASUCRE/LIPPENS (2)
Number of shares 2 463 666
% of capital 25.80%
% of voting rights 28.08%
  CARAVELLE
Number of shares 1 400 026
% of capital 14.66%
% of voting rights 22.06%
  Hélène MARTEL-MASSIGNAC
Number of shares 117
% of capital 0.00%

%

of voting rights

0.00%
  Total action in concert CARAVELLE/MARTEL-MASSIGNAC (4)
Number of shares 1 400 143
% of capital 14.66%
% of voting rights 22.06%
  Olivier RIGAUD
Number of shares 3 000
% of capital 0.03%
% of voting rights 0.03%
  Anne ABRIAT
Number of shares 3
% of capital 0.00%
% of voting rights 0.00%
  Miriam MAES
Number of shares 1
% of capital 0.00%
% of voting rights 0.00%
  Total other directors NATUREX
Number of shares 3 004
% of capital 0.03%
% of voting rights 0.03%
   ALLIANZ
Number of shares   521 783
% of capital   5.5%
% of voting rights   4.1%
   Bpi Participations
Number of shares    579 651
 % of capital   6.1%
% of voting rights   7.7%
   TIKEHAU
Number of shares     314 915
% of capital    3.3%
 % of voting rights   4.2%
   Total other identified shareolders
Number of shares     1 416 349
 % of capital    14.83%
 % of voting rights   16.08%
  Public
Number of shares 4 260 680
% of capital 44.62%
% of voting rights 33.72%
  TOTAL
Number of shares 9 548 741
% of capital 100.00%
% of voting rights 100.00%
 
 
 
 

(1) NATUREX S.A holds treasury shares within the framework of the liquidity contract concluded with Exane BNP Paribas. This shares have no exercisable voting rights attached for General Meeting.

(2) SGD's capital is held by FINASUCRE at 83.88% and Group UNIGRAINS entered to the capital at 16.03% on 9 July 2014 by subscription to the capital increase of SGD.

(3) An action in concert exists between SGD, NATUREx's lead shareholder and FINASUCRE in light of the existence of common Executive Officers for these two entities, Paul and Olivier LIPPENS, also Directors of NATUREX.

(4) CARAVELLE Group acquired on 5 December 2012 Natraceutical's stake (Natra Group) in NATUREX. Hélène MARTEL-MASSIGNAC, Chair and CEO of CARAVELLE, is also Director of NATUREX.

Sources : SGSS/GIS and NATUREX – December 2017

 

Analysts coverage

 
Company Analyst E-mail Adress City
BERENBERG CAPITAL MARKET Fintan RYAN Fintan.Ryan@berenberg.com 60 Threadneedle Street London EC2R 8HP, United Kingdom
CM-CIC Securities Louise BOYER louise.boyer@cmcics.com 6 avenue de Provence 75441 Paris Cedex 09
Davy Research Katy HUTCHINSON
Liz COEN
Katy.Hutchinson@davy.ie
Liz.Coen@davy.ie
Davy House, 49 Dawson St. Dublin 2, Ireland
EXANE BNP PARIBAS Martin BOERIS Martin.Boeris@exanebnpparibas.com 6 rue Ménars 75002 Paris
LOUIS CAPITAL MARKET Charles-Louis PLANADE clplanade@midcapp.com 39-41 rue Cambon 75001 Paris
NATIXIS SECURITIES Steve LEVY steve.levy@natixis.com 47 Quai d'Austerlitz 75648 Paris Cedex 13
SOCIETE GENERALE Marie-Line FORT marie-line.fort@sgcib.com Tour Société Générale - 17 Cours Valmy 92987 Paris La Défense Cedex
Société BERENBERG CAPITAL MARKET
Analyste Fintan RYAN
E-mail Fintan.Ryan@berenberg.com
Adresse 60 Threadneedle Street
Ville London EC2R 8HP,
United Kingdom
Société CM-CIC Securities
Analyste Louise BOYER
E-mail louise.boyer@cmcics.com
Adresse 6 avenue de Provence
Ville 75441 Paris Cedex 09
Société Davy Research
Analyste

Katy HUTCHINSON

Liz COEN

E-mail Katy.Hutchinson@davy.ie
Liz.Coen@davy.ie
Adresse Davy House,
49 Dawson St.
Ville Dublin 2, Ireland
Société EXANE BNP PARIBAS
Analyste Martin BOERIS
E-mail Martin.Boeris@exanebnpparibas.com
Adresse 6 Rue Ménars
Ville 75002 Paris
Société LOUIS CAPITAL MARKET
Analyste Charles-Louis PLANADE
E-mail clplanade@midcapp.com
Adresse 39-41 rue Cambon
Ville 75001 Paris
Société NATIXIS SECURITIES
Analyste Steve LEVY
E-mail steve.levy@natixis.com
Adresse 47 Quai d'Austerlitz
Ville 75648 Paris Cedex 13
Société SOCIETE GENERALE
Analyste Marie-Line FORT
E-mail marie-line.fort@sgcib.com
Adresse Tour Société Générale - 17 Cours Valmy
Ville 92987 Paris La Défense Cedex
 

ADR program

NATUREX implemented a Level I American Depositary Receipt (ADR) program, sponsored by BNY Mellon, as the depositary bank. The ADRs issued are eligible to trade on over-the-counter market in the United States since 16 December 2011, under the symbol NTUXY. To facilitate trades, ADRs were issued using a ratio of 4 ADRs for one ordinary share of NATUREX.

ADRs are U.S dollar-denominated negotiable instruments issued by a depositary bank. They can represent a fraction of a share, a single or multiple shares of the foreign stock. ADRs facilitate the purchase, holding and sale of non-U.S companies. ADRs can be held in book-entry form or as a physical certificate. The price of and ADR often tracks the price of the foreign stock in its home market, adjusted for the ratio of ADRs to foreign company shares. Level I depositary receipts are the first level of sponsored ADRs that can be issued and may only be traded on the OTC market. In addition to the ADR price being quoted in US Dollars, investors of ADR’s receive dividend payments and any other cash entitlements in US Dollars.

Depositary Bank

BNY Mellon
Depositary Receipts Division
101 Barclay Street
22nd Floor
New York, New York 10286
Facsimile - 212 571 3050/1/2
E-mail shrrelations@bnymellon.com
www.bnymellon.com/shareowner.

 
Back to top